Clinical Trials Directory

Trials / Completed

CompletedNCT05004818

Galvanic Vestibular Stimulation as a Novel Treatment for Seasickness

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
54 (actual)
Sponsor
Medical Corps, Israel Defense Force · Academic / Other
Sex
Male
Age
19 Years – 44 Years
Healthy volunteers
Accepted

Summary

subjects with severe seasickness, who failed to habituate to sea conditions after at least six month of active sailing, were enrolled to the single-blind randomized control study. The intervention group was treated with rotatory chair stimulation at sinusoidal harmonic acceleration protocol coupled with galvanic vestibular stimulation to the mastoid processes. This unique procedure was hypothesized to promote habituation to seasickness. The control group underwent a sham procedure. All study participants filled out seasickness questionnaires at set time points following the intervention and underwent repeated step testing to determine their vestibular time constant. The number of anti-motion sickness clinic visits and scopolamine prescriptions was also recorded in the three months period following the intervention.

Conditions

Interventions

TypeNameDescription
PROCEDUREGVS stimulation coupled with inverse phase rotatory chair stimulation at sinusoidal harmonic acceleration protocolGVS stimulation coupled with inverse phase rotatory chair stimulation at sinusoidal harmonic acceleration protocol
PROCEDURESham procedureParticipants with severe motion sickness were sited in the the rotatory chair with the videonystagmography recorder masking their eyes, while two galvanic vestibular stimulation electrodes were connected to the mastoid processes. No active stimulus was given.

Timeline

Start date
2016-08-01
Primary completion
2018-01-01
Completion
2019-07-01
First posted
2021-08-13
Last updated
2021-08-13

Source: ClinicalTrials.gov record NCT05004818. Inclusion in this directory is not an endorsement.